Staff Members - Benha University
Tumor necrosis factor alpha promoter polymorphism (308 G/A) in Egyptian patients with systemic lupus erythematosus
• 2015
Publication Information
Authors
Ibrahim M. Rageh1, Ahmed A. Sharaawy2, Ali I. Fouda3, Eman R. Abdelgawad1& Walid A. abdelhalim1
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Aims:The aim of this study was to evaluate the association between TNF-a gene polymorphism (308 G/A) and SLE in Egyptian population and evaluate the relation among this polymorphism with the activity and the clinical manifestations of SLE.
Subjects and methods: A case control study was performed on 50 female patients with systemic lupus erythematosus (mean age, 32.4±8.6 years) and 50 female healthy volunteers (mean age, 31.9±8.3 years) served as a controls. Genotyping was carried out by polymerase chain reaction, PCR products were digested by NcoI restriction enzyme. The digested PCR product was fractionated on 3% Agarose gel and visualized after staining by ethidium bromide.
Results: TNF (rs1800629) GA+AA genotypes and A allele were significantly increased in studied SLE patients when compared to healthy control subjects (p=0.023, 0.007 respectively), with high risk to develop SLE (OR=1.959, 95% CI=1.097-3.501; OR=3.020, 95% CI=1.319-6.914 respectively). TNF genotypes showed significant differences between various SLEDAI activity grades (p=0.012). Moreover, GG genotype had significantly lower incidence of renal disorders and persistent proteinuria when compared to AG or AA (p=0.006, 0.001 respectively). While AA genotype showed significantly higher neurologic disorder when compared to GG and AG (
Subjects and methods: A case control study was performed on 50 female patients with systemic lupus erythematosus (mean age, 32.4±8.6 years) and 50 female healthy volunteers (mean age, 31.9±8.3 years) served as a controls. Genotyping was carried out by polymerase chain reaction, PCR products were digested by NcoI restriction enzyme. The digested PCR product was fractionated on 3% Agarose gel and visualized after staining by ethidium bromide.
Results: TNF (rs1800629) GA+AA genotypes and A allele were significantly increased in studied SLE patients when compared to healthy control subjects (p=0.023, 0.007 respectively), with high risk to develop SLE (OR=1.959, 95% CI=1.097-3.501; OR=3.020, 95% CI=1.319-6.914 respectively). TNF genotypes showed significant differences between various SLEDAI activity grades (p=0.012). Moreover, GG genotype had significantly lower incidence of renal disorders and persistent proteinuria when compared to AG or AA (p=0.006, 0.001 respectively). While AA genotype showed significantly higher neurologic disorder when compared to GG and AG (